期刊文献+

新生儿胆汁淤积的临床特征和病因分析 被引量:14

Clinical features and etiology of cholestasis in neonates
原文传递
导出
摘要 目的总结新生儿胆汁淤积病例临床特征和病因,并分析早产儿和足月儿的差异。方法对2004年1月至2010年12月复旦大学儿科医院住院的176例新生儿胆汁淤积病例进行回顾性分析。淤胆病因分为胃肠外营养相关胆汁淤积(PNAC)、感染、胆道疾病、先天畸形或染色体疾病、遗传代谢性疾病、其他和原因不明7大类。将所有患儿按出生孕周分为足月儿组35例,早产儿组141例,观察两组喂养、静脉营养使用、感染史、缺氧史等胆汁淤积相关因素,以及发病时间、总胆红素和结合胆红素水平、肝脏受损情况、相关实验室指标等,并分析两组引起淤胆的病因和预后差异。结果早产儿组禁食、开奶、达到全量喂养、使用胃肠外营养的时间均明显长于足月儿组(均P〈0.01),使用全胃肠外及有感染史的比例均高于足月儿组(均P〈0.05);而足月儿发生淤胆、出现肝损伤的时间却明显早于早产儿(均P〈0.05)。足月儿组胆汁淤积治愈和好转率62.9%(22/35),明显低于早产儿组[82.3%(116/141),P=0.014]。足月儿淤胆病因中感染11例(31.4%)、胆道闭锁4例(11.4%)、先天畸形或染色体异常7例(20.0%)、遗传代谢性疾病3例(8.6%)、其他原因7例(20.0%)、不明原因3例(8.6%)。早产儿中达到PNAC诊断标准97例(68.8%),其平均出生孕周30+4(25+3~36+2)周;另44例(31.2%)早产儿不符合PNAC诊断,平均孕周33+3(27—36+5)周。其中感染21例、胆道疾病3例、遗传代谢性疾病2例、其他病因5例、原因不明13例。结论新生儿胆汁淤积病因繁多,相对而言足月儿和早产儿非PNAC胆汁淤积的病因更为复杂。有必要对住院新生儿进行常规筛查发现淤胆,对明确淤胆患儿应尽早病因诊断,并长期随访。 Objective To explore the clinical features and etiology of cholestasis in neonates, and elucidate the difference between preterm and term infants. Methods A retrospective study was conducted for 176 cases of cholestasis during neonatal periods from January 2004 to December 2010 of Children's Hospital of Fudan University. Their etiologies included parenteral nutrition-associated cholestasis (PNAC), infection, biliary tract disorders, congenital abnormalities and chromosomal disorders, metabolic diseases, others (prenatal hypoxia, post unconjugated hyperbilirubinemia, neonatal lupus and congenital chylothorax) and unknown reasons. They were also divided into term and preterm groups according to gestational age, the relative factors, such as feeding patterns, use of parenteral nutrition ( PN), infection and hypoxic history, and the clinical features, such as cholestasis onset age, bilirubin level, liver function and outcome were compared between two groups. Results The time of fasting, age of starting feeding, age of reaching to full feeding and the time of overall PN time were all longer in the preterm group than those in the term group ( all P 〈 0.01 ). The preterm group had more PN and infection cases ( all P 〈 0. 05). The term group presented earlier with cholestasis and liver function damage versus the preterm group ( both P 〈 0.05 ). The rate of recovery in term group is lower than in preterm group which is (62. 9% (22/35) vs 82. 3% ( 116/141 ), P=0. 014). The etiologies of 35 term infants were infection (n = 11, 31.4% ), biliary tract disorders (n =4, 11.4% ), congenital abnormalities and chromosomal disorders ( n = 7, 20.0% ), metabolic diseases (n = 3, 8.6% ), others (n = 7, 20. 0% ) and unknown reasons (n = 3, 8.6% ). There were 97 cases (68. 8% ) of PNAC in preterm infants and the average gestational age was 30 +4 (25 +3 _ 36 +2) weeks. And the etiologies of the remaining 44 ( 31.2% ) preterm cases without PNAC were infection ( n = 21 ),biliary tract disorders (n =3), metabolic diseases (n =2), others (n =5) and unknown reasons (n =13). Conclusions The etiologies of neonatal cholestasis are diverse. It may be more complicated in term and non-PNAC preterm infants. It is important to screen cholestasis in neonatal inpatients. Basic etiological elucidation and long-term follow-up are necessary for the positive cases.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第18期1259-1263,共5页 National Medical Journal of China
关键词 胆汁淤积 高胆红素血症 婴儿 新生 婴儿 早产 Cholestasis Hyperbilirubinemia Infant, newborn Infant, premature
  • 相关文献

参考文献13

  • 1汤庆娅,王莹,冯一,陶晔璇,吴江,蔡威.新生儿肠外营养相关胆汁淤积因素612例分析[J].中华儿科杂志,2007,45(11):838-842. 被引量:57
  • 2Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatie jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr, 2004, 39: 115-128.
  • 3Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat Clin Pract Gastrocnterol Hepatol, 2007, 4: 277-287.
  • 4Haresh K, Aideen M, Max P. Appendix 7 normal and reference values//Residents handbook of neonatology. 3th ed. Hamilton: B.C. Decker Inc, 2007: 556-577.
  • 5Dick MC, Mowat AP. Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up. Arch Dis Child, 1985, 60: 512-516.
  • 6Rocha G, Rocha P, Proenca E, et al. Disorders of the neonatal liver and bile ducts. Acta Med Port, 2011, 23: 767-776.
  • 7Sun W, Wang Y, Yang Y, et al. The screening of inborn errors of metabolism in sick Chinese infants by tandem mass spectrometry and gas chromatogTaphy/mass spectrometry. Clin Chim Acta, 2011,412: 1270-1274.
  • 8Ariza CR, Frati AC, Sierra I. Hypothyroidism-associated cholestasis. JAMA, 1984, 252: 2392.
  • 9Binder G, Martin D, Kanther I, et al. The course of neonatal cholestasis in congenital combined pituitary hormone deficiency. J Pediatr Endocrinol Metab, 2007, 20 : 695-702.
  • 10Allgood C, Bolisetty S. Severe conjugated hyperbilimbinaemia and neonatal haemolysis. Int J Clin Pract, 2006, 50: 1513-1514.

二级参考文献38

共引文献98

同被引文献128

  • 1李举,郝晓广.蓝光联合茵栀黄颗粒治疗新生儿病理性黄疸临床疗效分析[J].中国生化药物杂志,2014,34(1):121-122. 被引量:50
  • 2张澜,曹云.新生儿胃肠外营养相关性肝胆并发症研究进展[J].国外医学(儿科学分册),2005,32(3):185-187. 被引量:18
  • 3李志华,陈超,姚明珠.超低出生体重儿45例临床资料分析[J].临床儿科杂志,2005,23(6):375-376. 被引量:13
  • 4Seyed Mohsen Dehghani,Mahmood Haghighat,Mohammad Hadi Imanieh,Bita Geramizadeh.Comparison of different diagnostic methods in infants with Cholestasis[J].World Journal of Gastroenterology,2006,12(36):5893-5896. 被引量:15
  • 5Nightingale S, Ng VL. Optimizing nutritional management in children with chronic liver disease [ J ]. Pediatr Clin North Am, 2009, 56(5) :1161 -1183.
  • 6Mager DR, VWkes U, Roberts EA, et al. Branched -chain a- mino acid needs in children with mild -to -moderate chronic cholestatic liver disease[J]. J Nutr, 2006, 136(1): 133-139.
  • 7Bucuvalas JC, Horn JA, Chernausek SD. Resistance to growth hormone in children with chronic liver disease [J ]. Pediatr Transplant, 1997, 1 (1) .73 -79.
  • 8Smart KM, Alex G, Hardikar W. Feeding the child with liver disease., a review and practical clinical guide[ J]. J Gastroen- terol Hepatol, 2011, 26(5) : 810 -815.
  • 9Kelly DA. Preventing parenteral nutrition liver disease [ J ]. Early Hum Dev, 2010, 86(11) : 683 -687.
  • 10Tsiaousi ET, Hatzitolios AI, Trygonis SK, et al. Malnutrition in end stage liver disease., recommendations and nutritional support[ J ]. J Gastroenterol Hepatol, 2008, 23 (4) : 527 - 533.

引证文献14

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部